73 related articles for article (PubMed ID: 2974747)
21. Age-related regional loss of caudate-putamen dopamine receptors revealed by quantitative autoradiography.
Joyce JN; Loeschen SK; Sapp DW; Marshall JF
Brain Res; 1986 Jul; 378(1):158-63. PubMed ID: 2943360
[TBL] [Abstract][Full Text] [Related]
22. Striatal neurons express increased level of dopamine D2 receptor mRNA in response to haloperidol treatment: a quantitative in situ hybridization study.
Bernard V; Le Moine C; Bloch B
Neuroscience; 1991; 45(1):117-26. PubMed ID: 1754061
[TBL] [Abstract][Full Text] [Related]
23. Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ.
Neisewander JL; Ong A; McGonigle P
Synapse; 1995 Feb; 19(2):134-43. PubMed ID: 7725242
[TBL] [Abstract][Full Text] [Related]
24. Effects of irreversible dopamine receptor inactivation on locomotor activity and grooming in the 17- and 90-day-old rat.
McDougall SA; Crawford CA; Nonneman AJ
Psychopharmacology (Berl); 1992; 106(4):502-10. PubMed ID: 1349753
[TBL] [Abstract][Full Text] [Related]
25. Effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on the prolactin suppression induced by a series of full and partial dopamine D2 receptor agonists in male rats.
Ekman A; Eriksson E
Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):152-7. PubMed ID: 1360151
[TBL] [Abstract][Full Text] [Related]
26. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
Burger LY; Martin-Iverson MT
Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
[TBL] [Abstract][Full Text] [Related]
27. Evidence for dopamine D-2 receptors on cholinergic interneurons in the rat caudate-putamen.
Dawson VL; Dawson TM; Filloux FM; Wamsley JK
Life Sci; 1988; 42(20):1933-9. PubMed ID: 2966886
[TBL] [Abstract][Full Text] [Related]
28. Absence of receptor reserve at striatal dopamine receptors regulating cholinergic neuronal activity.
Meller E; Enz A; Goldstein M
Eur J Pharmacol; 1988 Oct; 155(1-2):151-4. PubMed ID: 2907486
[TBL] [Abstract][Full Text] [Related]
29. Evidence for a fast receptor turnover of D1 dopamine receptors in various forebrain regions of the rat.
Fuxe K; Agnati LF; Merlo Pich E; Meller E; Goldstein M
Neurosci Lett; 1987 Oct; 81(1-2):183-7. PubMed ID: 3320818
[TBL] [Abstract][Full Text] [Related]
30. Effects of the two partial D2 agonists (+)- and (-)-3-PPP on prolactin release in EEDQ treated male rats.
Ekman A; Quiding M; Eriksson E
Life Sci; 1991; 48(4):311-20. PubMed ID: 1671291
[TBL] [Abstract][Full Text] [Related]
31. Brain receptor autoradiography with [3H]-YM 09151-2: a ligand for labeling dopamine D-2 receptors.
Unis AS; Vincent JG; Dillon B
Life Sci; 1990; 47(25):PL151-5. PubMed ID: 2148202
[TBL] [Abstract][Full Text] [Related]
32. Localized alterations of dopamine receptor binding in rat brain by repeated electroconvulsive shock: an autoradiographic study.
Barkai AI; Durkin M; Nelson HD
Brain Res; 1990 Oct; 529(1-2):208-13. PubMed ID: 2149297
[TBL] [Abstract][Full Text] [Related]
33. Relationship between receptor occupancy and response at striatal dopamine autoreceptors.
Meller E; Bohmaker K; Namba Y; Friedhoff AJ; Goldstein M
Mol Pharmacol; 1987 Jun; 31(6):592-8. PubMed ID: 2885734
[TBL] [Abstract][Full Text] [Related]
34. Effect of aging on recovery of striatal dopamine receptors following N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) blockade.
Henry JM; Roth GS
Life Sci; 1984 Aug; 35(8):899-904. PubMed ID: 6482680
[TBL] [Abstract][Full Text] [Related]
35. Effect of cocaine self-administration on dopamine D2 receptors in rhesus monkeys.
Moore RJ; Vinsant SL; Nader MA; Porrino LJ; Friedman DP
Synapse; 1998 Sep; 30(1):88-96. PubMed ID: 9704885
[TBL] [Abstract][Full Text] [Related]
36. N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain.
Xu SX; Hatada Y; Black LE; Creese I; Sibley DR
J Pharmacol Exp Ther; 1991 May; 257(2):608-15. PubMed ID: 1674530
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneous distribution of dopamine D2 receptor mRNA in the rat striatum: a quantitative analysis with in situ hybridization histochemistry.
Szele FG; Artymyshyn R; Molinoff PB; Chesselet MF
Anat Rec; 1991 Dec; 231(4):548-58. PubMed ID: 1838906
[TBL] [Abstract][Full Text] [Related]
38. In vivo labeling of brain dopamine D2 receptors using the high-affinity specific D2 agonist [3H]CV 205-502.
Closse A; Camps M; Wanner A; Palacios JM
Brain Res; 1988 Feb; 440(1):123-32. PubMed ID: 2965955
[TBL] [Abstract][Full Text] [Related]
39. Regional variability in changes in 5-HT2A receptor mRNA levels in rat brain following irreversible inactivation with EEDQ.
Raghupathi RK; Artymyshyn R; McGonigle P
Brain Res Mol Brain Res; 1996 Jul; 39(1-2):198-206. PubMed ID: 8804728
[TBL] [Abstract][Full Text] [Related]
40. A high dose of EEDQ reduces pituitary dopamine D2 receptor density and the prolactin suppressive potency of agonists.
Ekman A; Eriksson E
Eur J Pharmacol; 1993 Oct; 243(3):295-9. PubMed ID: 7903944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
